A Study to Compare the Efficacy and Safety of HB1801 to Taxotere in Advanced Non-Small Cell Lung Cancer (NSCLC)
Clinical trial NCT05863325 · UNKNOWN
Trial details
- NCT number
- NCT05863325
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-27
- Primary completion
- 2024-03-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.